DHR — Danaher Corporation
Data coverage, completeness and provenance for Danaher Corporation in the Stock Market API — Health Care · Diagnostics & Research.
Stored price coverage
Source date: 2026-11-19T21:02:39. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-11-19 | 227.5600 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-18 | 228.5800 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-17 | 225.7700 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-16 | 229.9100 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-13 | 233.0200 | USD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/DHR/prices · Price parameters and adjustment semantics
No archived filings are currently stored for this listing.
Profile
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
Employees: 58,000 · Website: https://www.danaher.com · Profile fields populated: 75%
Data completeness by statement
Share of stored fields populated in the anchor reporting period (FY2025), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/DHR/financials.
Financial statement coverage (USD)
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2025 (USD) | 2025-12-31 | 31 | sec_edgar | ||||
| FY2024 (USD) | 2024-12-31 | 31 | sec_edgar | ||||
| FY2023 (USD) | 2023-12-31 | 31 | sec_edgar | ||||
| FY2022 (USD) | 2022-12-31 | 31 | sec_edgar | ||||
| FY2021 (USD) | 2021-12-31 | 31 | sec_edgar |
Get DHR data via the API
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Company profile
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/DHR
Financial statements
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/DHR/financials
Computed ratios
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/DHR/metrics/summary
News & announcements
Dated press releases and announcements with source links.
GET /api/v1/companies/DHR/news
Quick start
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/DHR
Query DHR programmatically
Free tier — instant API key. Built for AI agents.
Other NYSE · Health Care companies covered
Frequently Asked Questions
- What data does the API provide for DHR?
- Stored coverage for DHR: price data available, financial statements available, 0 archived filings. REST endpoints are under /api/v1/companies/DHR; inspect available source metadata for provenance.
- How complete is DHR's financial data?
- The anchor reporting period (FY2025) has 94.1% of the 17 core statement fields populated. Primary source: sec_edgar.
- What reporting periods are covered for DHR?
- 5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/DHR/financials.
- Where does DHR's data come from?
- Stored price source: yfinance. Primary source for the statement snapshot: sec_edgar. Inspect available period and field source tags at /api/v1/companies/DHR/financials; missing tags do not establish provenance.